| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1350 | 2020 |
| COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis RL Chua, S Lukassen, S Trump, BP Hennig, D Wendisch, F Pott, ... Nature biotechnology 38 (8), 970-979, 2020 | 1068 | 2020 |
| Semen-derived amyloid fibrils drastically enhance HIV infection J Münch, E Rücker, L Ständker, K Adermann, C Goffinet, M Schindler, ... Cell 131 (6), 1059-1071, 2007 | 651 | 2007 |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ... Cell 184 (26), 6243-6261. e27, 2021 | 376 | 2021 |
| HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor C Goffinet, I Allespach, S Homann, HM Tervo, A Habermann, D Rupp, ... Cell host & microbe 5 (3), 285-297, 2009 | 321 | 2009 |
| Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19 S Trump, S Lukassen, MS Anker, RL Chua, J Liebig, L Thürmann, ... Nature biotechnology 39 (6), 705-716, 2021 | 173 | 2021 |
| Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density S Geuenich, C Goffinet, S Venzke, S Nolkemper, I Baumann, P Plinkert, ... Retrovirology 5, 1-16, 2008 | 173 | 2008 |
| IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro C Prelli Bozzo, R Nchioua, M Volcic, L Koepke, J Krüger, D Schütz, ... Nature communications 12 (1), 4584, 2021 | 164 | 2021 |
| Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses M Yolamanova, C Meier, AK Shaytan, V Vas, CW Bertoncini, F Arnold, ... Nature nanotechnology 8 (2), 130-136, 2013 | 156 | 2013 |
| In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1. 24/tetherin in humans E Erikson, T Adam, S Schmidt, J Lehmann-Koch, B Over, C Goffinet, ... Proceedings of the National Academy of Sciences 108 (33), 13688-13693, 2011 | 112 | 2011 |
| Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1 C Meisel, B Akbil, T Meyer, E Lankes, VM Corman, O Staudacher, ... The Journal of clinical investigation 131 (14), 2021 | 86 | 2021 |
| Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics S Schroeder, F Pott, D Niemeyer, T Veith, A Richter, D Muth, C Goffinet, ... The Lancet Microbe 2 (5), e210-e218, 2021 | 82 | 2021 |
| Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation Anggakusuma, I Romero‐Brey, C Berger, CC Colpitts, T Boldanova, ... Hepatology 62 (3), 702-714, 2015 | 82 | 2015 |
| Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu C Goffinet, S Homann, I Ambiel, N Tibroni, D Rupp, OT Keppler, ... Journal of virology 84 (8), 4089-4094, 2010 | 81 | 2010 |
| Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19 G Nouailles, E Wyler, P Pennitz, D Postmus, D Vladimirova, J Kazmierski, ... Nature communications 12 (1), 4869, 2021 | 76 | 2021 |
| Efficient nonviral gene delivery into primary lymphocytes from rats and mice C Goffinet, OT Keppler The FASEB journal 20 (3), 500-502, 2006 | 73 | 2006 |
| HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription C Goffinet, I Allespach, OT Keppler Proceedings of the National Academy of Sciences 104 (3), 1015-1020, 2007 | 68 | 2007 |
| cGAS-mediated innate immunity spreads intercellularly through HIV-1 Env-induced membrane fusion sites S Xu, A Ducroux, A Ponnurangam, G Vieyres, S Franz, M Müsken, ... Cell host & microbe 20 (4), 443-457, 2016 | 54 | 2016 |
| 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1 V Lodermeyer, K Suhr, N Schrott, C Kolbe, CM Stürzel, D Krnavek, ... Retrovirology 10, 1-18, 2013 | 53 | 2013 |
| Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses C Goffinet, S Schmidt, C Kern, L Oberbremer, OT Keppler Journal of virology 84 (21), 11374-11384, 2010 | 52 | 2010 |
